Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: Results of the Accelerated Radiotherapy with Carbogen Breathing and Nicotinamide phase III randomized trial

S.E. Rademakers, I.J. Hoogsteen, P.F. Rijken, CH Terhaard, P.A.H. Doornaert, J.A. Langendijk, P. van den Ende, A.J. van der Kogel, J. Bussink, J.H. Kaanders

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)171-176
JournalHead and Neck
Volume37
Issue number2
DOIs
Publication statusPublished - 2015

Cite this

Rademakers, S. E., Hoogsteen, I. J., Rijken, P. F., Terhaard, CH., Doornaert, P. A. H., Langendijk, J. A., ... Kaanders, J. H. (2015). Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: Results of the Accelerated Radiotherapy with Carbogen Breathing and Nicotinamide phase III randomized trial. Head and Neck, 37(2), 171-176. https://doi.org/10.1002/hed.23569